4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-025389
Chief Scientific Officer sold 44,400 shares at an average $29.70 ($1,318,516)
- Chief Scientific Officer acquired 44,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-20 | Option exercise | +14,900 | $6.32 | $94,168 | 85,579 | D: show line 1 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-20 | Sale | −2,000 | $27.72 | $55,440 | 83,579 | D: show line 2 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-20 | Sale | −7,912 | $28.63 | $226,521 | 75,667 | D: show line 3 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-20 | Sale | −4,988 | $29.58 | $147,545 | 70,679 | D: show line 4 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-21 | Option exercise | +3,900 | $6.32 | $24,648 | 74,579 | D: show line 5 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-21 | Sale | −1,203 | $28.55 | $34,346 | 73,376 | D: show line 6 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-21 | Sale | −2,697 | $29.50 | $79,562 | 70,679 | D: show line 7 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-22 | Option exercise | +25,600 | $6.32 | $161,792 | 96,279 | D: show line 8 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-22 | Sale | −100 | $29.63 | $2,963 | 96,179 | D: show line 9 in the form |
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-22 | Sale | −25,500 | $30.28 | $772,140 | 70,679 | D: show line 10 in the form |
| Open-market sales · 44,400 sh · avg $29.70 · $1,318,516 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-20 | Option exercise · Stock Option (Right to Buy) | −14,900 | 540,700 | D: show line 11 in the form | |||||
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-21 | Option exercise · Stock Option (Right to Buy) | −3,900 | 536,800 | D: show line 12 in the form | |||||
| ROBINS HARLAN S Chief Scientific Officer | 2020-04-22 | Option exercise · Stock Option (Right to Buy) | −25,600 | 511,200 | D: show line 13 in the form |
Loading xslF345X03/doc4.xml…